Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of radiation therapy in malignant pleural mesothelioma: a systematic review.
Ung YC, Yu E, Falkson C, Haynes AE, Stys-Norman D, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Ung YC, et al. Among authors: haynes ae. Radiother Oncol. 2006 Jul;80(1):13-8. doi: 10.1016/j.radonc.2006.06.002. Epub 2006 Jul 3. Radiother Oncol. 2006. PMID: 16820238 Review.
Dose-intensive chemotherapy with growth factor or autologous bone marrow/stem cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a systematic review.
Verma S, Younus J, Stys-Norman D, Haynes AE, Blackstein M; Sarcoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Verma S, et al. Among authors: haynes ae. Cancer. 2008 Mar 15;112(6):1197-205. doi: 10.1002/cncr.23302. Cancer. 2008. PMID: 18224666 Free article. Review.
Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma.
Verma S, Younus J, Stys-Norman D, Haynes AE, Blackstein M; Members of the Sarcoma Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Verma S, et al. Among authors: haynes ae. Cancer Treat Rev. 2008 Jun;34(4):339-47. doi: 10.1016/j.ctrv.2008.01.005. Epub 2008 Mar 3. Cancer Treat Rev. 2008. PMID: 18313854
Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review.
Petrella T, Quirt I, Verma S, Haynes AE, Charette M, Bak K; Melanoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Petrella T, et al. Among authors: haynes ae. Cancer Treat Rev. 2007 Aug;33(5):484-96. doi: 10.1016/j.ctrv.2007.04.003. Epub 2007 Jun 11. Cancer Treat Rev. 2007. PMID: 17562357 Review.
Yttrium 90 ibritumomab tiuxetan in lymphoma.
Cheung MC, Haynes AE, Stevens A, Meyer RM, Imrie K; Members of the Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care. Cheung MC, et al. Among authors: haynes ae. Leuk Lymphoma. 2006 Jun;47(6):967-77. doi: 10.1080/10428190600572582. Leuk Lymphoma. 2006. PMID: 16840185 Review.
Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline.
Verma S, Younus J, Haynes AE, Stys-Norman D, Blackstein M; Sarcoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Verma S, et al. Among authors: haynes ae. Curr Oncol. 2008 Apr;15(2):80-4. doi: 10.3747/co.v15i2.162. Curr Oncol. 2008. PMID: 18454188 Free PMC article.
28 results